Ciprofloxacin: an overview and prospective appraisal.
D000284:Administration, Oral; D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy*; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D003550:Cystic Fibrosis / Q000188:drug therapy; D004195:Disease Models, Animal; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006801:Humans; D007263:Infusions, Parenteral; D008826:Microbial Sensitivity Tests; D010019:Osteomyelitis / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012749:Sexually Transmitted Diseases / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
D002939:Ciprofloxacin